NCT02971969

A Long-Term Follow-up Study to Evaluate the Safety, Tolerability, and Efficacy of Adeno-Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B

Study Summary

A long-term follow-up study to evaluate the safety, tolerability, and efficacy of DTX101 in adult males with moderate/severe to severe hemophilia B.

Want to learn more about this trial?

Request More Info

Interventions

No interventions listed.

Study Locations

FacilityCityStateCountry
Arkansas Children's HospitalLittle RockArkansasUnited States
UF CRC - Clinical Research CenterGainesvilleFloridaUnited States
University of Michigan Hospital and Health SystemsAnn ArborMichiganUnited States
Haemophilia, Haemostasis & Thrombosis CentreBasingstokeHampshireUnited Kingdom
Manchester Haemophilia Comprehensive Care CenterManchesterUnited Kingdom

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026